AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22134569 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 1% peeling
Number of subjects: 63
Study 19549306 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytotherapeutic combination treatment
Number of subjects: 93
Study 19549306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 17578985 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial motor response
Number of subjects: 26
Study 17578985 — intervention group
Group type: COMPARATOR
Intervention: Peroneal motor response
Number of subjects: 26
Study 15197195 — intervention group
Group type: COMPARATOR
Intervention: GV (gemcitabine 1000 mg/m(2) + vinorelbine 25 mg/m(2) on days 1 and 8 every 3 weeks)
Number of subjects: 300
Study 15197195 — intervention group
Group type: EXPERIMENTAL
Intervention: GVP (gemcitabine 1000 mg/m(2) + vinorelbine 25 mg/m(2) + cisplatin 75 mg/m(2) on day 2 every 3 weeks)
Number of subjects: 300
Study 15197195 — intervention group
Group type: COMPARATOR
Intervention: GV
Number of subjects: 300
Study 15197195 — intervention group
Group type: EXPERIMENTAL
Intervention: GVP
Number of subjects: 300
Study 15197195 — intervention group
Group type: EXPERIMENTAL
Intervention: GV and GVP
Number of subjects: 300
Study 15489869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg intravenously every 8 h
Number of subjects: 110
Study 15489869 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 10 microg/kg intravenously daily
Number of subjects: 110
Study 10077963 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy extracorporeal shockwave therapy (ESWT) with 250 impulses of 0.04 mJ/mm2
Number of subjects: 50
Study 10077963 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with shock-wave impact inhibited by a neopren insert
Number of subjects: 50
Study 10077963 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy extracorporeal shockwave therapy (ESWT)
Number of subjects: 50
Study 8834820 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk strategy package (HR)
Number of subjects: 294
Study 8834820 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamil Nadu Government package (TNG)
Number of subjects: 294
Study 8834820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 294
Study 2036345 — intervention group
Group type: EXPERIMENTAL
Intervention: Vernier targets
Number of subjects: 25
Study 7235851 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment on a research unit
Number of subjects: 56
Study 7235851 — intervention group
Group type: COMPARATOR
Intervention: Standard adult inpatient (nonresearch) units
Number of subjects: 56
Study 31793165 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 28
Study 31793165 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 28
Study 31793165 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lixisenatide and insulin glargine
Number of subjects: 28
Study 30876869 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fascia iliaca compartment block (FICB)
Number of subjects: 127
Study 30876869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 28069051 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine plus basic treatment (steroids and 5-aminosalicylic acid)
Number of subjects: 120
Study 28069051 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine plus basic treatment (steroids and 5-aminosalicylic acid)
Number of subjects: 120
Study 26750398 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip external rotator exercise program (5 times per week for four weeks)
Number of subjects: 28
Study 25090366 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered supportive-expressive group therapy
Number of subjects: 0
Study 25090366 — intervention group
Group type: COMPARATOR
Intervention: Coping effectiveness group training
Number of subjects: 0
Study 23102179 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g ground cinnamon
Number of subjects: 30
Study 23102179 — intervention group
Group type: COMPARATOR
Intervention: Plain cereal (control)
Number of subjects: 30
Study 19553931 — intervention group
Group type: EXPERIMENTAL
Intervention: PPAR-agonist treatment
Number of subjects: 2688
Study 19553931 — intervention group
Group type: COMPARATOR
Intervention: Non-PPAR drugs
Number of subjects: 2688
Study 19553931 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in adiponectin levels
Number of subjects: 2688
Study 17616069 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous treatment with 500 mg of sacharose ferric oxide (Venofer)
Number of subjects: 50
Study 15015147 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein restriction (0.71 g x kg(‐1) fat‐free mass x d(‐1))
Number of subjects: 2
Study 15015147 — intervention group
Group type: COMPARATOR
Intervention: Ample American-style protein intake (1.67 g x kg(‐1) fat‐free mass x d(‐1))
Number of subjects: 2
Study 11930875 — intervention group
Group type: COMPARATOR
Intervention: Standard pancreaticoduodenectomy
Number of subjects: 59
Study 11930875 — intervention group
Group type: COMPARATOR
Intervention: Standard lymph node dissection
Number of subjects: 59
Study 11930875 — intervention group
Group type: COMPARATOR
Intervention: Different types of pancreatic-enteric reconstruction
Number of subjects: 59
Study 11930875 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic gastrojejunostomy
Number of subjects: 59
Study 11930875 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical splanchnicectomy
Number of subjects: 59
Study 9537309 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg zinc (n = 68)
Number of subjects: 205
Study 9537309 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg zinc (n = 71)
Number of subjects: 205
Study 9537309 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 66)
Number of subjects: 205
Study 7702150 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural infusion of bupivacaine 0.2% with fentanyl 10 micrograms.ml‐1
Number of subjects: 33
Study 7702150 — intervention group
Group type: COMPARATOR
Intervention: Lumbar epidural infusion of bupivacaine 0.2% with fentanyl 10 micrograms.ml‐1
Number of subjects: 33
Study 29482412 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training, 2 times a week for 12 weeks
Number of subjects: 16
Study 29482412 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 16
Study 28404157 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly nab-paclitaxel (100 mg/m2, on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 741
Study 28404157 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel every 3 weeks (260 mg/m2, on day 1 of a 21-day cycle)
Number of subjects: 741
Study 28404157 — intervention group
Group type: COMPARATOR
Intervention: Weekly solvent-based paclitaxel (80 mg/m2, on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 741
Study 25739878 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose measles-virus-based candidate vaccine (1.5 x 10^4 TCID50 per 0.05 mL)
Number of subjects: 42
Study 25739878 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose measles-virus-based candidate vaccine (7.5 x 10^4 TCID50 per 0.25 mL)
Number of subjects: 42
Study 25739878 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose measles-virus-based candidate vaccine (3.0 x 10^5 TCID50 per 1.0 mL)
Number of subjects: 42
Study 25739878 — intervention group
Group type: EXPERIMENTAL
Intervention: Measles-virus-based candidate vaccine (all doses)
Number of subjects: 42
Study 25739878 — intervention group
Group type: COMPARATOR
Intervention: Priorix (active comparator)
Number of subjects: 42
Study 23128844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (nHF) ventilation for 8 hours
Number of subjects: 0
Study 23128844 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous breathing
Number of subjects: 0
Study 20338670 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention programme consisting of a series of lectures and videos
Number of subjects: 0
Study 20338670 — intervention group
Group type: COMPARATOR
Intervention: Control group (completed the same intervention programme after the study)
Number of subjects: 0
Study 17415030 — intervention group
Group type: EXPERIMENTAL
Intervention: MIST Therapy plus standard of wound care
Number of subjects: 70
Study 17415030 — intervention group
Group type: COMPARATOR
Intervention: Standard of wound care alone
Number of subjects: 70
Study 16313144 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT (30.3 degrees C, 76% RH)
Number of subjects: 13
Study 16313144 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (20.4 degrees C, 60% RH)
Number of subjects: 13
Study 12387552 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal and infancy home visiting by nurses
Number of subjects: 0
Study 10429608 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative splinting for 4 weeks
Number of subjects: 82
Study 10429608 — intervention group
Group type: COMPARATOR
Intervention: No postoperative splinting
Number of subjects: 82
Study 7473919 — intervention group
Group type: EXPERIMENTAL
Intervention: Human Growth Hormone (HGH) administration
Number of subjects: 69
Study 7473919 — intervention group
Group type: COMPARATOR
Intervention: No Human Growth Hormone (Control)
Number of subjects: 69
Study 2407228 — intervention group
Group type: EXPERIMENTAL
Intervention: Early shoulder mobilization (initiated on postoperative day 2)
Number of subjects: 57
Study 2407228 — intervention group
Group type: COMPARATOR
Intervention: Delayed shoulder mobilization (initiated on postoperative day 5)
Number of subjects: 57
Study 6794552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetate (90 mEq/day)
Number of subjects: 28
Study 6794552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31859245 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg belantamab mafodotin
Number of subjects: 196
Study 31859245 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.4 mg/kg belantamab mafodotin
Number of subjects: 196
Study 30667335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancouver risk calculator (VRC)
Number of subjects: 2813
Study 30667335 — intervention group
Group type: COMPARATOR
Intervention: ACR Lung Imaging Reporting and Data System (Lung‐RADS)
Number of subjects: 2813
Study 28799810 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT) on an active Power Plate® platform.
Number of subjects: 19
Study 28799810 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention on an inactive Power Plate® platform.
Number of subjects: 19
Study 28799810 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT) and sham intervention.
Number of subjects: 19
Study 25380179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 53
Study 25380179 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 53
Study 25633544 — intervention group
Group type: EXPERIMENTAL
Intervention: REBT-based intervention (8 sessions weekly: 6 individual and 2 group sessions)
Number of subjects: 160
Study 25633544 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 160
Study 25633544 — intervention group
Group type: EXPERIMENTAL
Intervention: REBT-based intervention
Number of subjects: 160
Study 25633544 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 21708047 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular reporting of spirometric results combined with smoking cessation advice by a primary care physician
Number of subjects: 485
Study 21708047 — intervention group
Group type: COMPARATOR
Intervention: Brief structured advice about giving up smoking (Control)
Number of subjects: 485
Study 19995206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with intra-ocular lenses (IOLs)
Number of subjects: 4738
Study 19995206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery in non-governmental organizations (NGO)/private facilities
Number of subjects: 4738
Study 19995206 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent cataract surgery
Number of subjects: 4738
Study 19995206 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, literacy, and urban residence
Number of subjects: 4738
Study 19995206 — intervention group
Group type: EXPERIMENTAL
Intervention: Refractive error and posterior capsule opacification
Number of subjects: 4738
Study 17376548 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-osmolar monomeric contrast medium (iomeprol-350, n=60)
Number of subjects: 216
Study 17376548 — intervention group
Group type: COMPARATOR
Intervention: Iso-osmolar dimeric contrast medium (iodixanol-320, n=60)
Number of subjects: 216
Study 17376548 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomeprol-300 (n=49)
Number of subjects: 216
Study 17376548 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol-320 (n=47)
Number of subjects: 216
Study 17376548 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomeprol (n=60)
Number of subjects: 216
Study 17376548 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol (n=60)
Number of subjects: 216
Study 17376548 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomeprol (n=49)
Number of subjects: 216
Study 17376548 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol (n=47)
Number of subjects: 216
Study 15839848 — intervention group
Group type: COMPARATOR
Intervention: Continuous Flicker Method (CFM)
Number of subjects: 56
Study 15839848 — intervention group
Group type: COMPARATOR
Intervention: Forced Choice Method (FCM)
Number of subjects: 56
Study 11927223 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral valacyclovir 2000 mg four times daily for 90 days
Number of subjects: 27
Study 11927223 — intervention group
Group type: COMPARATOR
Intervention: Oral acyclovir 200 mg four times daily for 90 days
Number of subjects: 27
Study 9793814 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg plus droperidol 0.625 mg (Group OD)
Number of subjects: 212
Study 9793814 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol 0.625 mg plus metoclopramide 10 mg (Group DM)
Number of subjects: 212
Study 9793814 — intervention group
Group type: EXPERIMENTAL
Intervention: perphenazine 5 mg (Group P)
Number of subjects: 212
Study 8569644 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nedocromil sodium 16 mg/day
Number of subjects: 22
Study 8569644 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nedocromil sodium 8 mg/day
Number of subjects: 22
Study 2692894 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripatellar methylprednisolone injection
Number of subjects: 38
Study 2692894 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular methylprednisolone injection
Number of subjects: 38
Study 1083668 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 78
Study 1083668 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery (subgroup with marked ischemic dysfunction)
Number of subjects: 78
Study 1083668 — intervention group
Group type: COMPARATOR
Intervention: Medically treated control group
Number of subjects: 78
Study 31324040 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectin supplementation (15 g/day for four weeks)
Number of subjects: 100
Study 31324040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30672196 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat sensitive moxibustion combined with articular injection of triamcinolone, 2 courses, 2 weeks as a course, 5 times a week.
Number of subjects: 67
Study 30672196 — intervention group
Group type: COMPARATOR
Intervention: Articular injection of triamcinolone, 2 courses, 2 times as a course, once every 5 days.
Number of subjects: 67
Study 27146064 — intervention group
Group type: EXPERIMENTAL
Intervention: Design effect approach
Number of subjects: 0
Study 27146064 — intervention group
Group type: COMPARATOR
Intervention: Analytical method
Number of subjects: 0
Study 23907526 — intervention group
Group type: EXPERIMENTAL
Intervention: Salinity increase (from 5 to 30 psu)
Number of subjects: 0
Study 23907526 — intervention group
Group type: EXPERIMENTAL
Intervention: Salinity decrease (from 30 to 5 psu)
Number of subjects: 0
Study 22460270 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel + Sunitinib (DS arm: docetaxel 60 mg m(‐2) every 3 weeks + sunitinib 37.5 mg every day)
Number of subjects: 107
Study 22460270 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel only (D only arm: 60 mg m(‐2), every 3 weeks)
Number of subjects: 107
Study 22460270 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel + Sunitinib (DS arm)
Number of subjects: 107
Study 19680302 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing socks over normal footwear
Number of subjects: 30
Study 19680302 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (unadulterated footwear)
Number of subjects: 30
Study 17218893 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-exercise
Number of subjects: 19
Study 17218893 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent-games
Number of subjects: 19
Study 17218893 — intervention group
Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 19
Study 16263857 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 60
Study 16263857 — intervention group
Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 60
Study 12011193 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk in to Work Out pack
Number of subjects: 295
Study 12011193 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the pack six months later)
Number of subjects: 295
Study 10203159 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 56
Study 10203159 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 56
Study 7785637 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartPrep
Number of subjects: 109
Study 7785637 — intervention group
Group type: COMPARATOR
Intervention: Control (standard 70-sec delay)
Number of subjects: 109
Study 1694714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 1694714 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg
Number of subjects: 17
Study 1694714 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine 180 mg
Number of subjects: 17
Study 1694714 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg + Terfenadine 180 mg
Number of subjects: 17
Study 7392399 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex stage-by-stage rehabilitation
Number of subjects: 233
Study 7392399 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 233
Study 29160135 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest therapy (P group)
Number of subjects: 70
Study 29160135 — intervention group
Group type: COMPARATOR
Intervention: No therapy (C group)
Number of subjects: 70
Study 26259627 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 0
Study 26259627 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0
Study 26259627 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0
Study 26259627 — intervention group
Group type: COMPARATOR
Intervention: hERG potassium channel blocking drugs (Dofetilide and Moxifloxacin)
Number of subjects: 0
Study 25194614 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v (5 × 10(9) cfu per capsule, 2 capsules daily for 8 weeks)
Number of subjects: 0
Study 25194614 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules daily for 8 weeks)
Number of subjects: 0
Study 25194614 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (L. plantarum 299 v and placebo)
Number of subjects: 0
Study 25194614 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v
Number of subjects: 0
Study 25194614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22669171 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 120
Study 22669171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 20472253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (1.5 g of n‐3 long‐chain polyunsaturated fatty acid/day)
Number of subjects: 78
Study 20472253 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (control)
Number of subjects: 78
Study 18343039 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol combined with norethisterone acetate
Number of subjects: 19
Study 18343039 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of testosterone, LH, and FSH
Number of subjects: 19
Study 18343039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 16212456 — intervention group
Group type: EXPERIMENTAL
Intervention: Color duplex ultrasound (CDUS)
Number of subjects: 178
Study 16212456 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 178
Study 12909222 — intervention group
Group type: COMPARATOR
Intervention: External beam radiotherapy (EBRT) alone (Group 1)
Number of subjects: 31
Study 12909222 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of external beam radiotherapy (EBRT) and high-dose-rate intraluminal brachytherapy (ILBT) (Group 2)
Number of subjects: 31
Study 12909222 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EBRT and ILBT (Group 2)
Number of subjects: 31
Study 12909222 — intervention group
Group type: COMPARATOR
Intervention: EBRT alone (Group 1)
Number of subjects: 31
Study 10318656 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (high-dose)
Number of subjects: 10948
Study 10318656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10948
Study 8852097 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education programme on pain assessment and management
Number of subjects: 106
Study 1776336 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PGI2 and molsidomine
Number of subjects: 0
Study 1776336 — intervention group
Group type: COMPARATOR
Intervention: Single administration of PGI2
Number of subjects: 0
Study 1776336 — intervention group
Group type: COMPARATOR
Intervention: Single administration of molsidomine
Number of subjects: 0